Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Hepatic Diseases and Disorders Excellence Forum

Hepatic Diseases and Disorders
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Conference Coverage
Paul Kwo, MD, on the Changing Face of Liver Disease
10/23/2023
Dr Kwo focused his David Sun Lecture at the ACG Postgraduate Course on the increasing burden of metabolic-associated fatty liver disease and the need to step up efforts to increase access to effective treatments now available for patients...
Dr Kwo focused his David Sun Lecture at the ACG Postgraduate Course on the increasing burden of metabolic-associated fatty liver disease and the need to step up efforts to increase access to effective treatments now available for patients...
Dr Kwo focused his David Sun...
10/23/2023
Gastroenterology
Blanca Lizaolo-Mayo
Video
Blanca Lizaola-Mayo, MD, on Changes in Nomenclature for Liver Diseases
09/20/2023
Dr Lizaolo-Mayo explains the recent changes in nomenclature from nonalcoholic fatty liver disease and why these changes were implemented.
Dr Lizaolo-Mayo explains the recent changes in nomenclature from nonalcoholic fatty liver disease and why these changes were implemented.
Dr Lizaolo-Mayo explains the...
09/20/2023
Gastroenterology
Gideon Hirschfield
Podcast
Progress in PBC: Seladelpar in Trial as Second-Line Therapy
07/20/2023

featuring Gideon Hirschfield, MD

featuring Gideon Hirschfield, MD ...
Dr Gideon Hirschfield from the University of Toronto Centre for Liver Disease discusses the potential of new drugs, including selective PPAR agents such as seladelpar, for the treatment of primary biliary cholangitis.
Dr Gideon Hirschfield from the University of Toronto Centre for Liver Disease discusses the potential of new drugs, including selective PPAR agents such as seladelpar, for the treatment of primary biliary cholangitis.
Dr Gideon Hirschfield from the...
07/20/2023
Gastroenterology
Sarah Khan
Video
Sarah Khan, MD, on Outcomes in Liver Patients With Fungal and Bacterial Infection
05/15/2023
Dr Khan recaps the results of research at Cleveland Clinic on how patients with acute-on-chronic liver failure with bacterial infections vs fungal infections fared in terms of mortality and other metrics.
Dr Khan recaps the results of research at Cleveland Clinic on how patients with acute-on-chronic liver failure with bacterial infections vs fungal infections fared in terms of mortality and other metrics.
Dr Khan recaps the results of...
05/15/2023
Gastroenterology
Juan Pablo Arab
Conference Coverage
Juan Pablo Arab, MD, on Referring Patients With Alcoholic Hepatitis for Liver Transplantation
05/09/2023
Dr Arab discusses his address from Digestive Disease Week 2023 on determining appropriate candidates among patients with alcohol-related liver disease, including hepatitis, for liver transplantation.
Dr Arab discusses his address from Digestive Disease Week 2023 on determining appropriate candidates among patients with alcohol-related liver disease, including hepatitis, for liver transplantation.
Dr Arab discusses his address...
05/09/2023
Gastroenterology
Alan Bonder
Podcast
Alan Bonder, MD, and Juan Pablo Arab, MD, on Alcohol-Related Liver Disease: Part 2
02/28/2023
In part 2 of their podcast, Drs Alan Bonder and Juan Pablo Arab review treatment for alcohol-related liver disease, including liver transplantation, and the importance of multidisciplinary care for treatment of ALD and alcohol use disorder.
In part 2 of their podcast, Drs Alan Bonder and Juan Pablo Arab review treatment for alcohol-related liver disease, including liver transplantation, and the importance of multidisciplinary care for treatment of ALD and alcohol use disorder.
In part 2 of their podcast, Drs...
02/28/2023
Gastroenterology
Hirsh Trivedi
Conference Coverage
Hirsh Trivedi, MD, on the Era of Combinations for NASH/NAFLD
02/21/2023

Hirsh Trivedi, MD

Transplant Hepatologist, Cedars-Sinai Medical Center

Los Angeles, California

Hirsh Trivedi, MD Transplant Hepatol...
Dr Trivedi reviews promising advances in combination therapies for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, as well as new options for diagnosis that help avoid the need for liver biopsy, from The Liver Meeting 2022.
Dr Trivedi reviews promising advances in combination therapies for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, as well as new options for diagnosis that help avoid the need for liver biopsy, from The Liver Meeting 2022.
Dr Trivedi reviews promising...
02/21/2023
Gastroenterology
Alan Bonder
Podcast
Alan Bonder, MD, and Juan Pablo Arab, MD on Alcohol-Related Liver Disease: Part 1
02/14/2023
Dr Alan Bonder from Beth Israel Deaconess Medical Center, and Dr Juan Pablo Arab, from the Schulich School of Medicine of Western University in Ontario, Canada, discuss the prevalence of alcohol-related liver disease, working compassionately...
Dr Alan Bonder from Beth Israel Deaconess Medical Center, and Dr Juan Pablo Arab, from the Schulich School of Medicine of Western University in Ontario, Canada, discuss the prevalence of alcohol-related liver disease, working compassionately...
Dr Alan Bonder from Beth Israel...
02/14/2023
Gastroenterology
Astrid Ruiz Margain
Video
Astrid Ruiz Margain, PhD, on Nutrition and Liver Disease
02/01/2023
Dr Ruiz reviews key presentations on nutrition in liver disease from the AASLD meeting, with emphasis on outcomes in cirrhosis related to sarcopenia, liver transplant, hepatocellular carcinoma, and nutritional therapy.
Dr Ruiz reviews key presentations on nutrition in liver disease from the AASLD meeting, with emphasis on outcomes in cirrhosis related to sarcopenia, liver transplant, hepatocellular carcinoma, and nutritional therapy.
Dr Ruiz reviews key...
02/01/2023
Gastroenterology
Lim
Video
Nicholas Lim, MD, on Updates in Liver Transplantation
01/31/2023
Dr Lim reviews key findings from abstracts at The Liver Meeting 2022 pertaining to liver transplantation.
Dr Lim reviews key findings from abstracts at The Liver Meeting 2022 pertaining to liver transplantation.
Dr Lim reviews key findings from...
01/31/2023
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
Multivariable Model Outperforms Guideline-Based Model for Predicting CRC
05/14/2024

Jolynn Tumolo

Jolynn Tumolo
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model...
05/14/2024
Gastroenterology
News
CRC Rate Rising Among Younger Americans
05/14/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate...
05/14/2024
Gastroenterology
News
MASLD Identified as Osteoarthritis Risk Marker in US Adults
05/03/2024

Jolynn Tumolo

Jolynn Tumolo
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated...
05/03/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
04/08/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
04/08/2024
Advances in Inflammatory Bowel Disease Network
News
IBS Prevalence Slightly Above 6% in Pandemic-Era US Survey
03/28/2024

Jolynn Tumolo

Jolynn Tumolo
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed...
03/28/2024
Gastroenterology
News
H. Pylori Infection Studied for Association With Colorectal Cancer
03/12/2024

Jolynn Tumolo

Jolynn Tumolo
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter...
03/12/2024
Gastroenterology
News
Metabolic Health Does Not Protect Against Erosive Esophagitis in Adults With Obesity
03/08/2024

Jolynn Tumolo

Jolynn Tumolo
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body...
03/08/2024
Gastroenterology
News
Intrarectal Injections of BoNTA for Fecal Incontinence?
03/04/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate...
03/04/2024
Gastroenterology
News
GLP-1 Treatment Associated With Lower CRC Risk
02/27/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
Patients treated for type 2 diabetes with glucagon-like peptide 1 receptor agonists were at lower risk of developing colorectal cancer, researchers found.
Patients treated for type 2 diabetes with glucagon-like peptide 1 receptor agonists were at lower risk of developing colorectal cancer, researchers found.
Patients treated for type 2...
02/27/2024
Gastroenterology
News
1 in 5 Patients with Erosive Esophagitis Cycles Through PPIs
02/23/2024

Jolynn Tumolo

Jolynn Tumolo
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump inhibitor therapy was low among patients with erosive esophagitis, researchers found.
Persistence with any proton pump...
02/23/2024
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement